Tenon Medical, Inc. Payments of Stock Issuance Costs
Tenon Medical, Inc. (TNON) reported Payments of Stock Issuance Costs of $433.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsOfStockIssuanceCosts · last filed 2026-08-13
- Tenon Medical, Inc. payments of stock issuance costs for the quarter ending 2026-06-30 was $0.00, a 100.00% decline year-over-year.
- Tenon Medical, Inc. payments of stock issuance costs for the quarter ending 2026-03-31 was $433.00K, a 46.41% decline year-over-year.
- Tenon Medical, Inc. payments of stock issuance costs for the quarter ending 2025-12-31 was $120.00K.
- Tenon Medical, Inc. payments of stock issuance costs for the quarter ending 2025-09-30 was -$59.00K, a 105.67% decline year-over-year.
- Tenon Medical, Inc. payments of stock issuance costs for fiscal 2025 was $928.00K, a 15.33% decline from fiscal 2024.
- Tenon Medical, Inc. payments of stock issuance costs for fiscal 2024 was $1.10M.
| Period end | Payments of Stock Issuance Costs 3 month | Payments of Stock Issuance Costs 6 month | Payments of Stock Issuance Costs 9 month | Payments of Stock Issuance Costs 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $433.00K 10-Q · filed 2026-08-13 | $553.00K derived: sum of 3 quarters · filed 2026-08-13 | $494.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | $433.00K 10-Q · filed 2026-05-15 | $553.00K derived: sum of 2 quarters · filed 2026-05-15 | $494.00K derived: sum of 3 quarters · filed 2026-05-15 | $553.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | $120.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | $61.00K derived: sum of 2 quarters · filed 2026-03-27 | $120.00K derived: sum of 3 quarters · filed 2026-08-13 | $928.00K 10-K · filed 2026-03-27 |
| 2025-09-30 | -$59.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $0.00 derived: sum of 2 quarters · filed 2026-08-13 | $808.00K 10-Q · filed 2025-11-13 | $639.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | $59.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $867.00K 10-Q · filed 2026-08-13 | $698.00K derived: sum of 3 quarters · filed 2026-08-13 | $1.74M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | $808.00K 10-Q · filed 2026-05-15 | $639.00K derived: sum of 2 quarters · filed 2026-05-15 | $1.68M derived: sum of 3 quarters · filed 2026-05-15 | $1.68M derived: sum of 4 quarters · filed 2026-05-15 |
| 2024-12-31 | -$169.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | $872.00K derived: sum of 2 quarters · filed 2026-03-27 | $872.00K derived: sum of 3 quarters · filed 2026-03-27 | $1.10M 10-K · filed 2026-03-27 |
| 2024-09-30 | $1.04M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $1.04M derived: sum of 2 quarters · filed 2025-11-13 | $1.26M 10-Q · filed 2025-11-13 | |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | $224.00K 10-Q · filed 2025-08-13 | ||
| 2024-03-31 | $224.00K 10-Q · filed 2025-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |